Stay updated on ESMART: Molecular Stratification Clinical Trial
Sign up to get notified when there's something new on the ESMART: Molecular Stratification Clinical Trial page.

Latest updates to the ESMART: Molecular Stratification Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added; the funding-status notice and the prior revision note (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedI implemented a new site notice about the lapse in government funding and the NIH Clinical Center status, including guidance to visit cc.nih.gov and opm.gov. The page also shows Revision: v3.4.1, replacing the prior v3.4.0 tag.SummaryDifference0.2%

- Check28 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded a new experimental Arm R Capivasertib + metronomic Vinorelbine with dosing details and drug synonyms AZD5363 and TRUQAP, expanding the study's treatment options. Updated contacts: Estelle Jullemier is now listed; Jonathan Rubino's contact was removed.SummaryDifference1%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing v3.3.3. This is a backend versioning update and does not alter study details, eligibility criteria, endpoints, or locations.SummaryDifference0.0%

- Check63 days agoChange DetectedVal De Marne was added as a study location. The Val De Marne Locations entry was removed, and the revision updated from v3.3.2 to v3.3.3.SummaryDifference0.1%

Stay in the know with updates to ESMART: Molecular Stratification Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ESMART: Molecular Stratification Clinical Trial page.